{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:40:00Z","timestamp":1782974400931,"version":"3.54.5"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR129529"],"award-info":[{"award-number":["NIHR129529"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2022,3,28]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>During the COVID-19 pandemic, the British governments issued temporary approvals enabling the use of both medical abortion pills, mifepristone and misoprostol, at home. This permitted the introduction of a fully telemedical model of abortion care with consultations taking place via telephone or video call and medications delivered to women\u2019s homes. The decision was taken by the governments in England and Wales to continue this model of care beyond the original end date of April 2022, while at time of writing the approval in Scotland remains under consultation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We interviewed 30\u2009women who had undergone an abortion in England, Scotland or Wales between August and December 2021. We explored their views on the changes in abortion service configuration during the pandemic and whether abortion via telemedicine and use of abortion medications at home should continue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Support for continuation of the permission to use mifepristone and misoprostol at home was overwhelmingly positive. Reasons cited included convenience, comfort, reduced stigma, privacy and respect for autonomy. A telemedical model was also highly regarded for similar reasons, but for some its necessity was linked to safety measures during the pandemic, and an option to have an in-person interaction with a health professional at some point in the care pathway was endorsed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The approval to use abortion pills at home via telemedicine is supported by women having abortions in Britain. The voices of patients are essential to shaping acceptable and appropriate abortion service provision.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjsrh-2022-201502","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:39:17Z","timestamp":1653305957000},"page":"288-294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic"],"prefix":"10.1136","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-5730","authenticated-orcid":false,"given":"Patricia A","family":"Lohr","sequence":"first","affiliation":[{"name":"Centre for Reproductive Research and Communication, British Pregnancy Advisory Service, Stratford-upon-Avon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-1132","authenticated-orcid":false,"given":"Maria","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-8576","authenticated-orcid":false,"given":"Rebecca","family":"Meiksin","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Salaria","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-2276","authenticated-orcid":false,"given":"Sharon","family":"Cameron","sequence":"additional","affiliation":[{"name":"NHS Lothian, Chalmers Centre, Edinburgh, UK"},{"name":"Queen\u2019s Medical Research Institute, University of Edinburgh MRC Centre for Reproductive Health, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-823X","authenticated-orcid":false,"given":"Rachel H","family":"Scott","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Reiter","sequence":"additional","affiliation":[{"name":"Public Health, Lambeth Local Authority, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-8070","authenticated-orcid":false,"given":"Melissa J","family":"Palmer","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-5022","authenticated-orcid":false,"given":"Rebecca S","family":"French","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1053-8640","authenticated-orcid":false,"given":"Kaye","family":"Wellings","sequence":"additional","affiliation":[{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2025090221281604000_48.4.288.1","unstructured":"Department of Health & Social Care (DHSC) . Abortion statistics, England and Wales: 2020, 2021. Available: https:\/\/www.gov.uk\/government\/statistics\/abortion-statistics-for-england-and-wales-2020\/abortion-statistics-england-and-wales-2020"},{"key":"2025090221281604000_48.4.288.2","unstructured":"National Institute for Health and Care Excellence (NICE) . Abortion care. NICE guideline [NG140], 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng140"},{"key":"2025090221281604000_48.4.288.3","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG), Faculty of Sexual & Reproductive Healthcare (FSRH) British Society of Abortion Care Providers (BSACP) . Clinical Guidelines for Early Medical Abortion at Home--England. Rationale and Scope, 2019. Available: https:\/\/www-temp.rcog.org.uk\/media\/2bhntouz\/early-medical-abortion-at-home-guideline-england.pdf"},{"key":"2025090221281604000_48.4.288.4","unstructured":"Department of Health & Social Care (DHSC) . The Abortion Act 1967 - Approval of a Class of Places; 2020. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/876740\/30032020_The_Abortion_Act_1967_-_Approval_of_a_Class_of_Places.pdf"},{"key":"2025090221281604000_48.4.288.5","unstructured":"Scottish Government . Abortion: Covid-19: Approval for Mifepristone to be Taken at Home and Other Contingency Measures, 2020. Available: https:\/\/www.sehd.scot.nhs.uk\/cmo\/CMO(2020)09.pdf"},{"key":"2025090221281604000_48.4.288.6","unstructured":"Welsh Government . The Abortion Act 1967 - Approval of a Class of Place for Treatment for the Termination of Pregnancy (Wales) 2020, 2020. Available: https:\/\/gov.wales\/sites\/default\/files\/publications\/2020-04\/approval-of-a-class-of-place-for-treatment-for-the-termination-of-pregnancy-wales-2020.pdf"},{"key":"2025090221281604000_48.4.288.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200976"},{"key":"2025090221281604000_48.4.288.8","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG), Royal College of Midwives (RCM), Faculty of Sexual & Reproductive Healthcare (FSRH) British Society of Abortion Care Providers (BSACP) . Coronavirus (COVID-19) infection and abortion care. information for healthcare professionals, 2020. Available: https:\/\/www.rcog.org.uk\/media\/bbhpl2qa\/2020-07-31-coronavirus-covid-19-infection-and-abortion-care.pdf"},{"key":"2025090221281604000_48.4.288.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003934"},{"key":"2025090221281604000_48.4.288.10","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.10.084046"},{"key":"2025090221281604000_48.4.288.11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"key":"2025090221281604000_48.4.288.12","unstructured":"Jane R , Lewis J . Qualitative research practice\u202f: a guide for social science students and researchers. Sage Publications, 2003: 336 p."},{"key":"2025090221281604000_48.4.288.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200764"},{"key":"2025090221281604000_48.4.288.14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.contraception.2015.06.011","article-title":"If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion","volume":"92","author":"Gold","year":"2015","journal-title":"Contraception"},{"key":"2025090221281604000_48.4.288.15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2015.06.026","article-title":"A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S","volume":"92","author":"Chong","year":"2015","journal-title":"Contraception"},{"key":"2025090221281604000_48.4.288.16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/1471-0528.16765","article-title":"10-Year evaluation of the use of medical abortion through telemedicine: a retrospective cohort study","volume":"129","author":"Nort\u00e9n","year":"2022","journal-title":"BJOG"},{"key":"2025090221281604000_48.4.288.17","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16813"},{"key":"2025090221281604000_48.4.288.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2021.04.027"},{"key":"2025090221281604000_48.4.288.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200954"},{"key":"2025090221281604000_48.4.288.20","article-title":"Early medical abortion by telemedicine in the United Kingdom: a costing analysis","author":"Hawkins","year":"2021","journal-title":"BJOG"},{"key":"2025090221281604000_48.4.288.21","unstructured":"NHS England . Digital-first primary care and its implications for general practice payments; 2018. https:\/\/www.engage.england.nhs.uk\/survey\/digital-first-primary-care\/user_uploads\/digital-first-access-to-gp-care-engagement-v2.pdf"},{"key":"2025090221281604000_48.4.288.22","unstructured":"Parliament votes to make telemedicine for early medical abortion permanent in England Royal College of Obstetricians & Gynaecologists. Available: https:\/\/www.rcog.org.uk\/news\/parliament-votes-to-make-telemedicine-for-early-medical-abortion-permanent-in-england\/ [Accessed 11\/04\/2022]."},{"key":"2025090221281604000_48.4.288.23","unstructured":"Department of Health . No decision about me, without me liberating the NHS: government response; 2012. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/216980\/Liberating-the-NHS-No-decision-about-me-without-me-Government-response.pdf"},{"key":"2025090221281604000_48.4.288.24","unstructured":"National Institute for Health and Care Excellence (NICE) . Shared decision making. NICE guidance [CG197], 2021. Available: https:\/\/www.nice.org.uk\/guidance\/ng197"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2022-201502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:28:25Z","timestamp":1756873705000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2022-201502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10,12]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjsrh-2022-201502"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2022-201502","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.17.22271080","asserted-by":"object"}]},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}